Patents by Inventor Vincent Matthew Crowley

Vincent Matthew Crowley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SECOND GENERATION GRP94-SELECTIVE INHIBITORS
    Publication number: 20210300872
    Abstract: The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compound are also provided.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 30, 2021
    Inventors: Brian S.J. Blagg, Vincent Matthew Crowley
  • Second generation GRP94-selective inhibitors
    Patent number: 11028041
    Abstract: The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compounds are also provided.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: June 8, 2021
    Assignee: University of Kansas
    Inventors: Brian S. J. Blagg, Vincent Matthew Crowley
  • SECOND GENERATION GRP94-SELECTIVE INHIBITORS
    Publication number: 20200190017
    Abstract: The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compounds are also provided.
    Type: Application
    Filed: August 23, 2018
    Publication date: June 18, 2020
    Inventors: Brian S.J. Blagg, Vincent Matthew Crowley